In addition, we also observed in our in vitro study that a STAT3 inhibitor increased CXCL9 expression in tumor cells, indicating the balance of p-STAT1/p-STAT3 was a determinant in regulating chemokine production in tumor cells. This evidence concerns the gene CXCL9 and neoplasm.